imatinib mesylate has been researched along with Uveal Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Amorini, AM; Anfuso, CD; Distefano, A; Giallongo, C; Giurdanella, G; Longo, A; Lupo, G; Salmeri, M; Zanghì, G | 1 |
| Calipel, A; De La Fouchardière, A; Landreville, S; Mascarelli, F; Mouriaux, F; Penel, N; Rivoire, M | 1 |
| Clisant, S; Delcambre, C; Durando, X; Fournier, C; Hebbar, M; Isambert, N; Mascarelli, F; Mouriaux, F; Negrier, S; Penel, N | 1 |
| Aldrich, W; Dombos, C; Triozzi, PL | 1 |
| Becker, JC; Hofmann, UB; Houben, R; Kauczok-Vetter, CS | 1 |
| Smalley, KS; Sondak, VK; Weber, JS | 1 |
| Abramson, DH; Daniels, AB | 1 |
| Abourbih, D; Antecka, E; Burnier, MN; Castiglione, E; Di Cesare, S; Fernandes, BF; Isenberg, J; Maloney, S; Martins, C; Neto Belfort, R | 1 |
| Caltabiano, G; Queirolo, P; Spagnolo, F | 1 |
| Auclair, C; Calipel, A; Glotin, AL; Kherrouche, Z; Lefevre, G; Mascarelli, F; Maurage, CA; Mouriaux, F; Tran, T | 1 |
| All-Ericsson, C; Brodin, B; Girnita, L; Larsson, O; Müller-Brunotte, A; Ostman, A; Seregard, S | 1 |
| Cree, IA; Di Nicolantonio, F; Glaysher, S; Hungerford, JL; Hurren, J; Knight, LA; Lamont, A; Mercer, SJ; Sharma, S; Whitehouse, PA | 1 |
| Babchia, N; Calipel, A; Faussat, AM; Mascarelli, F; Mouriaux, F | 1 |
2 review(s) available for imatinib mesylate and Uveal Neoplasms
| Article | Year |
|---|---|
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
Topics: Animals; Benzamides; Humans; Imatinib Mesylate; Melanocytes; Melanoma; Melanoma, Experimental; Mice; Models, Biological; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Signal Transduction; Stem Cell Factor; Uveal Neoplasms | 2009 |
Uveal melanoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Chemotherapy, Adjuvant; Humans; Imatinib Mesylate; Immunotherapy; Ipilimumab; Liver Neoplasms; Melanoma; Piperazines; Pyrimidines; Uveal Neoplasms | 2012 |
2 trial(s) available for imatinib mesylate and Uveal Neoplasms
| Article | Year |
|---|---|
O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.
Topics: Abdominal Pain; Administration, Oral; Aged; Antineoplastic Agents; Benzamides; Disease Progression; Female; Humans; Imatinib Mesylate; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines; Survival Rate; Uveal Neoplasms | 2008 |
Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Topics: Aged; Aged, 80 and over; Benzamides; Female; Humans; Imatinib Mesylate; Male; Melanoma; Middle Aged; Mutation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Stem Cell Factor; Up-Regulation; Uveal Neoplasms | 2009 |
9 other study(ies) available for imatinib mesylate and Uveal Neoplasms
| Article | Year |
|---|---|
Uveal Melanoma Cells Elicit Retinal Pericyte Phenotypical and Biochemical Changes in an in Vitro Model of Coculture.
Topics: Becaplermin; Cancer-Associated Fibroblasts; Cell Movement; Cell Proliferation; Coculture Techniques; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Matrix Metalloproteinase 9; Melanoma; Neoplasm Proteins; Pericytes; Receptor, Platelet-Derived Growth Factor beta; Retina; Transforming Growth Factor beta1; Tumor Microenvironment; Uveal Neoplasms; Wound Healing | 2020 |
Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Humans; Imatinib Mesylate; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stem Cell Factor; Treatment Outcome; Uveal Neoplasms | 2014 |
Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Humans; Imatinib Mesylate; Melanoma; Mice; Piperazines; Pyrimidines; Temozolomide; Uveal Neoplasms; Xenograft Model Antitumor Assays | 2008 |
c-KIT in uveal melanoma: big fish or red herring?
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Melanoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Uveal Neoplasms | 2009 |
Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanoma.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Male; Melanoma; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Piperazines; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyrimidines; Rabbits; Time Factors; Tumor Burden; Uveal Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis.
Topics: Base Sequence; Benzamides; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Primers; Gene Expression; Humans; Imatinib Mesylate; Melanocytes; Melanoma; Mitogens; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Small Interfering; Signal Transduction; Stem Cell Factor; Uvea; Uveal Neoplasms | 2004 |
c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Blotting, Western; Cell Division; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Melanoma; Middle Aged; Paraffin Embedding; Phosphorylation; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Messenger; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine; Uveal Neoplasms | 2004 |
The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Signal Transduction; Skin Neoplasms; Uveal Neoplasms | 2006 |
17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Benzoquinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclins; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Silencing; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; Lactams, Macrocyclic; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Small Interfering; Uveal Neoplasms | 2008 |